Breast Cancer
FY25 Breakthrough Award - Funding Level 3 - Clinical Trial
The list of Fiscal Year 2025 Breast Cancer Research Program Breakthrough Award - Funding Level 3 - Clinical Trial applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| ProteinQure, Inc. | Dave Garman |
Last updated Thursday, February 19, 2026